Platelet transfusion refractoriness
- 8 July 2008
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 142 (3), 348-360
- https://doi.org/10.1111/j.1365-2141.2008.07189.x
Abstract
The platelet, a fascinating anucleate cell, is critically important for haemostasis. Platelet transfusions have greatly reduced the incidence of major haemorrhagic complications associated with the management of haematological and oncological disorders. However, some patients fail to receive the full benefit of platelet transfusions because they do not achieve the appropriate platelet count increment following transfusion. This review will discuss the aetiology, diagnosis, and management of refractoriness to platelet transfusion, a complicated problem for both the treating physicians and the transfusion services supporting these patients. Although advances have been made in the diagnosis and treatment of immune-mediated platelet refractoriness, which is usually caused by anti-human leucocyte antigen antibodies, non-immune causes, such as sepsis, remain problematic.Keywords
This publication has 117 references indexed in Scilit:
- Drug-Induced Immune ThrombocytopeniaNew England Journal of Medicine, 2007
- Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregationJCI Insight, 2006
- Slow infusion of platelets: A possible alternative in the management of refractory thrombocytopenic patientsAmerican Journal of Hematology, 2005
- DNA yield from buccal swabs and its utilization in HLA typing using luminex SSO bead technologyHuman Immunology, 2004
- Screening for alloantibodies in the serum of patients receiving platelet transfusions: a comparison of the ELISA, lymphocytotoxicity, and the indirect immunofluorescence methodTransfusion, 2003
- Selecting donors of platelets for refractory patientson the basis of HLA antibody specificityTransfusion, 2000
- Recommendations for off-label use of intravenously administered immunoglobulin preparations. University Hospital Consortium Expert Panel for Off-Label Use of Polyvalent Intravenously Administered Immunoglobulin PreparationsPublished by American Medical Association (AMA) ,1995
- Intestinal platelet trapping after traumatic and septic shock. An early sign of sepsis and multiorgan failure in critically ill patients?Critical Care Medicine, 1992
- Use of leucocyte‐poor blood components and HLA‐matched‐platelet donors to prevent HLA alloimmunizationBritish Journal of Haematology, 1986
- Graft-versus-Host Disease and Survival in Patients with Aplastic Anemia Treated by Marrow Grafts from HLA-Identical SiblingsNew England Journal of Medicine, 1983